Victory Capital Management
INBX

Victory Capital Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Victory Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-43,560
Closed -$1.07M – 2757
2022
Q4 		$1.07M Sell
43,560
-33,300
-43% -$979K ﹤0.01% 1704
2022
Q3 		$1.38M Sell
76,860
-12,200
-14% -$220K ﹤0.01% 1592
2022
Q2 		$1.01M Sell
89,060
-10,891
-11% -$160K ﹤0.01% 1745
2022
Q1 		$2.16M Buy
99,951
+16,998
+20% +$434K ﹤0.01% 1471
2021
Q4 		$3.62M Sell
82,953
-62,687
-43% -$2.51M ﹤0.01% 1400
2021
Q3 		$4.85M Buy
145,640
+76,310
+110% +$2.32M ﹤0.01% 1338
2021
Q2 		$1.91M Sell
69,330
-4,420
-6% -$92K ﹤0.01% 1649
2021
Q1 		$1.48M Sell
73,750
-30,450
-29% -$889K ﹤0.01% 1736
2020
Q4 		$3.44M Sell
104,200
-16,230
-13% -$432K ﹤0.01% 1346
2020
Q3 		$2.17M Buy
+120,430
New +$2.18M ﹤0.01% 1417

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Victory Capital Management's INBX Position: Q1 2023 in Review

Victory Capital Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2023, closing a stake of 43,560 shares — an estimated $1.07M sold.

Victory Capital Management first reported a position in INBX in Q3 2020 and held it in 10 quarters. The position peaked at $4.85M in Q3 2021. 108 funds tracked by Wall St. Rank hold INBX as of Q1 2023.

  • Victory Capital Management reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Victory Capital Management sold 43,560 Inhibrx, Inc. Common Stock shares in Q1 2023, an estimated $1.07M.
  • Victory Capital Management first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 10 quarters.
  • Victory Capital Management's Inhibrx, Inc. Common Stock position peaked at $4.85M in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2023.

Based on Victory Capital Management's 13F filing for Q1 2023, filed 2 May 2023.